Anthony
$30M for Cancer-Focused TAE Life Sciences
Tiny Yet Mighty: Nanotechnology in Radiation Therapy
TAE Life Sciences Secures $30M in Initial B Round Phase to Accelerate Development of Unique Boron Delivery Drugs for Novel Cancer Treatment
TAE Life Sciences Announces Scientific Advisory Board to Advance Cancer Research in Boron-Neutron Capture Therapy
TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding
Have questions about BNCT? Get answers on our new BNCT Forum